COX- 2 selektive hæmmere reducerer dannelsen af systemiske (og dermed muligvis endotel- deriveret) prostacyclin uden at påvirke thromboxani blodpladerne.
COX-2 selective inhibitors reduce the formation of systemic (and therefore possibly endothelial) prostacyclin without affecting platelet thromboxane.